FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2963032127> ?p ?o ?g. }

• W2963032127 endingPage "2457" @default.
• W2963032127 startingPage "2437" @default.
• W2963032127 abstract "Background: A series of novel pyrazolopyrimidine and pyrazololpyridine thioglycosides were synthesized and confirmed via their spectral analyses. Purpose: To evaluate the effect of these anti-metabolic compounds against proliferation of Huh-7 and Mcf-7 as in vitro models of human liver and breast cancers, respectively. Vero cells were used as an example of normal green monkey kidney cells. Methods: The most promising compound was subjected to a nanoformulation by its encapsulation into chitosan nanoparticles to increase its anti-cancerous activity. Nanoformulation was confirmed by TEM and FT-IR to ensure encapsulation and screened for their cytotoxicity against Huh-7 and Mcf-7 cells using MTT colorimetric assay and morphological examination. Genotoxic effect was performed by cellular DNA fragmentation assay. Simulated CompuSyn software (linear interaction effect) was conducted to predict the possible synergistic effect of nanocomposite as anticancerous activity. Apoptotic effect was further analyzed by detection of apoptotic proteins using ELISA assay. Results: The nano preparation was successfully prepared by encapsulation of compound 14 into chitosan nanoparticles, controlled to a size at 105 nm and zeta charges at 40.2 mV. Treatment of Huh-7 and Mcf-7 showed that compound 14 was the most cytotoxic compound on both cancer cell lines where IC50 was 24.59 (9.836 μg/mL) and 12.203 (4.8812 μg/mL) on Huh-7 and Mcf-7 respectively. But IC50 of the nano preparation was 37.19 and 30.68 μg/mL on Huh-7 and Mcf-7, respectively, indicating its aggressiveness on human breast cancer cells as confirmed by DNA fragmentation assay and theoretically by CompuSyn tool. Conclusion: A novel series of pyrazolopyrimidine thioglycosides and pyrazolopyridine thioglycosides were synthesized. Nanoformulation of compound 14 into chitosan nanoparticles demonstrated anticancer activity and can be used as a drug delivery system, but further studies are still required." @default.
• W2963032127 created "2019-07-30" @default.
• W2963032127 creator A5024807903 @default.
• W2963032127 creator A5032176085 @default.
• W2963032127 creator A5069817637 @default.
• W2963032127 creator A5091386014 @default.
• W2963032127 date "2019-07-01" @default.
• W2963032127 modified "2023-10-14" @default.
• W2963032127 title "<p>Novel purine thioglycoside analogs: synthesis, nanoformulation and biological evaluation in in vitro human liver and breast cancer models</p>" @default.
• W2963032127 cites W1167674590 @default.
• W2963032127 cites W1969666381 @default.
• W2963032127 cites W1971645600 @default.
• W2963032127 cites W1975207418 @default.
• W2963032127 cites W1980984482 @default.
• W2963032127 cites W1981333917 @default.
• W2963032127 cites W1982262593 @default.
• W2963032127 cites W1982304840 @default.
• W2963032127 cites W1994986226 @default.
• W2963032127 cites W2001808858 @default.
• W2963032127 cites W2015993339 @default.
• W2963032127 cites W2020575441 @default.
• W2963032127 cites W2027178679 @default.
• W2963032127 cites W2054526986 @default.
• W2963032127 cites W2056966258 @default.
• W2963032127 cites W2065837924 @default.
• W2963032127 cites W2069786744 @default.
• W2963032127 cites W2073299869 @default.
• W2963032127 cites W2073418794 @default.
• W2963032127 cites W2074447551 @default.
• W2963032127 cites W2077945404 @default.
• W2963032127 cites W2093985454 @default.
• W2963032127 cites W2096439168 @default.
• W2963032127 cites W2103562758 @default.
• W2963032127 cites W2106014206 @default.
• W2963032127 cites W2155633893 @default.
• W2963032127 cites W2165889876 @default.
• W2963032127 cites W2219143077 @default.
• W2963032127 cites W2438633553 @default.
• W2963032127 cites W2489919208 @default.
• W2963032127 cites W2512924511 @default.
• W2963032127 cites W2562970979 @default.
• W2963032127 cites W2563055809 @default.
• W2963032127 cites W2598256830 @default.
• W2963032127 cites W2608627022 @default.
• W2963032127 cites W2609769402 @default.
• W2963032127 cites W2731680745 @default.
• W2963032127 cites W2739584575 @default.
• W2963032127 cites W2766304080 @default.
• W2963032127 cites W2766304507 @default.
• W2963032127 cites W2770963697 @default.
• W2963032127 cites W2772848405 @default.
• W2963032127 cites W2784125767 @default.
• W2963032127 cites W2793104880 @default.
• W2963032127 cites W2795842519 @default.
• W2963032127 cites W2803489069 @default.
• W2963032127 cites W2808962638 @default.
• W2963032127 cites W2885461960 @default.
• W2963032127 cites W2894086351 @default.
• W2963032127 cites W2908740605 @default.
• W2963032127 cites W2975127032 @default.
• W2963032127 doi "https://doi.org/10.2147/dddt.s201249" @default.
• W2963032127 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6667681" @default.
• W2963032127 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31440030" @default.
• W2963032127 hasPublicationYear "2019" @default.
• W2963032127 type Work @default.
• W2963032127 sameAs 2963032127 @default.
• W2963032127 citedByCount "17" @default.
• W2963032127 countsByYear W29630321272020 @default.
• W2963032127 countsByYear W29630321272021 @default.
• W2963032127 countsByYear W29630321272022 @default.
• W2963032127 countsByYear W29630321272023 @default.
• W2963032127 crossrefType "journal-article" @default.
• W2963032127 hasAuthorship W2963032127A5024807903 @default.
• W2963032127 hasAuthorship W2963032127A5032176085 @default.
• W2963032127 hasAuthorship W2963032127A5069817637 @default.
• W2963032127 hasAuthorship W2963032127A5091386014 @default.
• W2963032127 hasBestOaLocation W29630321271 @default.
• W2963032127 hasConcept C109316439 @default.
• W2963032127 hasConcept C109541995 @default.
• W2963032127 hasConcept C121608353 @default.
• W2963032127 hasConcept C153911025 @default.
• W2963032127 hasConcept C154317977 @default.
• W2963032127 hasConcept C185592680 @default.
• W2963032127 hasConcept C190283241 @default.
• W2963032127 hasConcept C202751555 @default.
• W2963032127 hasConcept C2776231280 @default.
• W2963032127 hasConcept C2777752497 @default.
• W2963032127 hasConcept C2780783641 @default.
• W2963032127 hasConcept C2994423619 @default.
• W2963032127 hasConcept C31573885 @default.
• W2963032127 hasConcept C43759708 @default.
• W2963032127 hasConcept C530470458 @default.
• W2963032127 hasConcept C54355233 @default.
• W2963032127 hasConcept C55493867 @default.
• W2963032127 hasConcept C86803240 @default.
• W2963032127 hasConcept C89138240 @default.
• W2963032127 hasConcept C96232424 @default.
• W2963032127 hasConcept C98274493 @default.

• next